Positron emission tomography (PET) for diagnosis of renal cell carcinoma (RCC);DIE POSITRONENEMISSIONS-TOMOGRAPHIE ZUR DIAGNOSTIK DES NIERENZELLKARZINOMS

Urologe - Ausgabe A

Volumn 35, Issue 2, 1996, Pages 146-150

  Bachor, R ^a   Kotzerke, J ^a   Gottfried, H W ^a   Brandie E ^a   Reske, S N ^a   Hautmann, R ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

positron emission tomography; renal cell cancer; staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GLUCOSE BLOOD LEVEL; KIDNEY TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SCINTISCANNING;

BLOOD GLUCOSE; CARCINOMA, RENAL CELL; DEOXYGLUCOSE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029933411     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Amendola MA, King LR, Pollack HM, Gefter W, Kressel HY, Wein AJ (1990) Staging of renal carcinoma using magnetic resonance imaging at 1.5 Tesla. Cancer 66: 40-44
2. Bachor R, Kocher F, Gropengießer F, Reske SN, Hautmann R (1995) Positronenemissionstomographie - Einführung eines neuen Verfahrens in die Diagnostik urologischer Tumoren und erste klinische Ergebnisse. Urologe [A] 34:138-142
3. Benson MA, Haaga JR, Resnick MI (1989) Staging renal carcinoma - what is sufficient? Arch Surg 124: 71-73
4. Beyer-Enke SA, Strauss LG, Zeitler E (1991) Welche Bedeutung hat die PET heute in der Tumordiagnostik? Fortschr Med 109: 595-598
5. DiChiro G, Hatazawa J, Katz DA, Rizzoli HV, deMichele DJ (1987) Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology: 164: 521-526
6. Fein AB, Lee JKT, Balfe DM, Heiken JP, Ling D, Glazer HS, McClennan BL (1987) Diagnosis and staging of renal cell carcinoma: a comparison of MR imaging and CT. AJR 148: 749-753
7. Frohmüller HGW, Grups JW, Heller V (1987) Comparative value of ultrasonography, computerized tomography, angiography and excretory urography in the staging of renal cell carcinoma. J Urol 138: 482-484
8. Gardner SF, Green JA, Bednarczyk EM, Farnett L, Miraldi F (1992) Principles and clinical applications of positron emission tomography. Am J Hosp Pharm 49: 1400-1506
9. Haberkorn U, Strauss LG, Reißer C, van Kaick G (1992) Positronenemissionstomographie (PET) zur Beurteilung von Tumorproliferation und Therapieverlauf bei HNO-Tumoren. Radiologe 32: 296-301
10. Hawkins RA, Hoh C, Glaspy J, Rege S, Choi Y, Phelps ME (1994) Positron emission tomography scanning in cancer. Cancer Invest 12: 74-87
11. Hoffman JM, Hanson MW, Coleman RE (1993) Clinical positron emission tomography imaging. Radiol Clin North Am 31: 935-959
12. Hricak H, Thoeni RF, Carroll PR, Demas BE, Marotti M, Tanagho EA (1988) Detection and staging of renal neoplasms: a reassessment of MR imaging. Radiology 166: 643-649
13. Hundeshagen H, Biersack HJ, Bull U, Felix R, Gunnewig BJ, Heiss WD, Hor G, Jordan K, Knapp WH, Muller-Gartner HW, Reiners C, Reske S, Schicha H, Schober O, Schwaiger M, Stocklin G, Strauss LG (1994) Positronen-Emissions-Tomographie: Klinische Forschung, diagnostische Wertigkeit, zukünftige Entwicklung: Standortbestimmung 1994. Nukl Med 33: 145-153
14. Jacobson HG (1988) Positron emission tomography in oncology. JAMA 259: 2126-2131
15. Johnson CD, Dunnick NR, Cohan RH, Illescas FF (1987) Renal adenocarcinoma: CT staging of 100 tumors. AJR 148: 59-63
16. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R, Ido T (1990) Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31: 1927-1933
17. Maisey M, Jeffery P (1991) Clinical applications of positron emission tomography. BJCP 45: 265-272
18. Minn H, Joensuu H, Ahonen A, Klemi P (1988) Fluorodeoxyglucose imaging a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 61: 1776-1781
19. Müller-Mattheis V, Reinhardt M, Müller-Gärtner HW, Ackermann R (1995) Differenzierung von Raumforderungen der Niere durch die Positronen-Emissionstomosraphie mit 2-[18F]-2-deoxy-D-glucose (18 FDG-PET). Urologe [A] (Suppl) 34:103
20. Palko A, Kuhn E, Grexa E, Hertelendy A (1990) Renal cell carcinoma: value of imaging examinations in diagnosis and staging. Fortschr Röntgenstr 153: 585-590
21. Schlag P, Lehner B, Strauss LG, Georgi P, Herfarth C (1989) Scar or recurrent rectal cancer. Arch Surg 124: 197-200
22. Schmitz-Dräger BJ, Ebert T (1994) Nierenparenchymtumoren. In: Jocham D, Miller K (Hrsg) Praxis der Urologie in zwei Bänden. Thieme, Stuttgart New York, S 7-35
23. Schober O, Meyer GJ (1992) Beurteilung von Hirntumoren mit der Positronenemissionstomographie. Radiologe 32: 282-289
24. Schönberger JA, Stollfuß JC, Port M, Grillenberger KG, Büchler M, Beger HG, Reske SN (1994) Association of glucose-transporter 1 gene activation to FDG-uptake in human pancreatic adenocarcinoma. Abstract Europ Assoc Nucl Med, Dusseldorf, Germany
25. Shtern F (1992) Positron emission tomography as a diagnostic tool. A reassessment based on literature review. Invest Radiol 27:165-168
26. Smith SJ, Bosniak MA, Megibow AJ, Hulnick DH, Horii SC, Raghavendra BN (1989) Renal cell carcinoma: earlier discovery and increased detection. Radiology 170: 699-703
27. Wilson CBJH (1992) PET scanning in oncology. Eur J Cancer 28: 508-510